ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Consent Tracking for Clinical Samples"
Episode Synopsis
Tracking patient consent for the use of their samples in clinical trials is essential to both minimize risk of non-compliance and maximizing potential for future use.
In this episode, Barbara Nagaraj, Sr. IT Architect at BioFortis, a Q2 Solutions company, explains informed consent for patient samples and the importance of easily tracking consent as samples move through the clinical trial ecosystem.
She describes:
How consent is or has been documented
The benefits of electronic consent documentation
Specific consent attributes, e.g. genetic testing
Handling consent requirements from different countries or institutions
Understanding consent for future use, including limitations and expirations
Learn more at https://www.q2labsolutions.com/labmatrix
In this episode, Barbara Nagaraj, Sr. IT Architect at BioFortis, a Q2 Solutions company, explains informed consent for patient samples and the importance of easily tracking consent as samples move through the clinical trial ecosystem.
She describes:
How consent is or has been documented
The benefits of electronic consent documentation
Specific consent attributes, e.g. genetic testing
Handling consent requirements from different countries or institutions
Understanding consent for future use, including limitations and expirations
Learn more at https://www.q2labsolutions.com/labmatrix
More episodes of the podcast Laboratory Considerations for Clinical Trials
Managing Sample Data from Vendors
14/09/2021
Automation within an ADME Laboratory
26/08/2021
Bioanalytical Automation of Samples
30/07/2021
In God we trust